When DDR1 expression was correlated with available clinicopathologic parameters, this revealed that higher expression levels were evident in higher-grade, higher-stage tumors and significantly correlated to the presence of lymph node metastasis. This evidence concerns the gene DDR1 and metastatic malignant neoplasm in the lymph nodes.